The Path from Biomarker Discovery to Regulatory Qualification

Focuses on biomarker qualification, its history and regulatory settings in both the US and abroad. This book provides a look at the next step to developing biomarkers for clinical use and covers overall concepts, challenges, strategies and solutions based on the experiences of regulatory authorities and scientists.